NCAM1 and breast cancer: In our previous work, polysialylation and polysialylated NCAM were both elevated under TGF-β treatment[28], overexpression of NCAM-140 significantly promoted cell proliferation, motility and migration in BC cells[22], which is consistent with the present study (Figure 3C‒F).